Onvansertib in Combination With Abiraterone and Prednisone in Adult Patients With Metastatic Castration-Resistant Prostate Cancer
Clinical trial NCT03414034 · COMPLETED
Trial details
- NCT number
- NCT03414034
- Sponsor
- Cardiff Oncology
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-14
- Primary completion
- 2023-10-16
- Enrollment
- 72
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.